Ellmers, Leigh J <br/><br/>
Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.  [electronic resource] 

 -  Journal of cardiovascular pharmacology  Mar 2015 
 - 269-75 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-4023 
<br/><br/><label>Standard No.: </label>10.1097/FJC.0000000000000190  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cardiotonic Agents--pharmacology<br/>Collagen Type I--genetics<br/>Disease Models, Animal<br/>Fibrosis<br/>Gene Expression Regulation<br/>Hemodynamics--drug effects<br/>Hypertrophy, Left Ventricular--genetics<br/>Male<br/>Mice, Inbred C57BL<br/>Myocardial Contraction--drug effects<br/>Myocardial Infarction--drug therapy<br/>Myocardium--metabolism<br/>Myosin Heavy Chains--genetics<br/>RNA, Messenger--metabolism<br/>Recovery of Function<br/>Stroke Volume--drug effects<br/>Time Factors<br/>Urocortins--pharmacology<br/>Ventricular Dysfunction, Left--genetics<br/>Ventricular Function, Left--drug effects<br/>Ventricular Remodeling--drug effects